T[he]{.smallcaps} L1 CAM^1^ family of cell adhesion molecules (comprised of L1, NgCAM, NrCAM, CHL1, and neurofascin) is a major contributor to intercellular interactions in the vertebrate nervous system ([@B21]; [@B6]). L1 CAM molecules, which are represented in *Drosophila* by neuroglian ([@B5]), possess variable extracellular domains composed of six Ig domains, three to five fibronectin type III domains, and a relatively conserved cytoplasmic domain ([@B43]; [@B21]). Extracellular domains of L1 CAMs participate in homophilic interactions as well as a variety of interactions with soluble proteins and other cell adhesion molecules ([@B21]; [@B6]). Extensive diversity in extracellular interactions of L1 CAM family members is provided by divergence between extracellular domains encoded by different genes as well as multiple alternatively spliced variants of each gene (as many as 50 estimated in the case of neurofascin) ([@B19]). Consistent with the diverse extracellular domains, a range of functions has been attributed to the L1 CAM family, including axon fasciculation, axonal guidance, neurite extension, a role in long term potentiation, synaptogenesis, and myelination ([@B21]; [@B46]; [@B6]).

Mutations in the human L1 gene, located on the X chromosome, are responsible for mental retardation, as well as hydrocephalus, abnormal development of major axon pathways in the corpus callosum and corticocospinal tract, and motor deficits ([@B41]; [@B26]; [@B47]; [@B15]). Penetrance of L1 mutations is variable, except for mental retardation, which is the most common abnormality. The term CRASH (corpus callosum agenesis, mental retardation, adducted thumbs, spastic paraplegia, and hydrocephalus) has been used to describe general features of L1 mutations ([@B14]). Over 35 mutations in L1 have currently been characterized, and these are distributed in all domains, including several in the cytoplasmic domain ([@B45]; [@B16]). Disruption of the L1 gene in mice results in abnormal axon guidance in the corticospinal tract, brain malformations (including dilated ventricles), and behavioral deficits ([@B9]; [@B8]; [@B17]). These observations demonstrate the physiological importance of L1 in normal development of the nervous system as well as a role of L1 in human disorders.

The cytoplasmic domains of L1 CAM family members share a conserved sequence that has been demonstrated to associate with high affinity with ankyrins, a family of spectrin-binding proteins located on the cytoplasmic surface of the plasma membrane ([@B10]; [@B12]; [@B18]; [@B22]; [@B48]). The association between ankyrins and L1 CAMs is regulated by phosphorylation of the FIGQY tyrosine, a site which is conserved among vertebrate and invertebrate members of the L1CAM family ([@B18]; [@B44]). Ankyrins also associate with the voltage-gated Na channel, Na/K ATPase, anion channel, and Na/Ca exchanger. Ankyrins have been proposed to form lateral complexes between these ion channels and members of the L1 CAM family ([@B36],*b*; [@B4]).

The ankyrin family currently includes three genes encoding ankyrin~R~, ankyrin~B~, and ankyrin~G~ polypeptides as well as multiple alternatively spliced variants encoded by each gene ([@B40]; [@B4]). 440-kD ankyrin~B~ and 480-kD ankyrin~G~ polypeptides are the major isoforms in the developing nervous system and are localized in premyelinated and unmyelinated axons ([@B31]; [@B39]; [@B7]; [@B30]; [@B32]). These axonal ankyrins have a predicted ball-and-chain configuration, with an extended tail domain inserted between the COOH- terminal death domain and globular head domain. The head domain is composed of membrane- and spectrin-binding domains ([@B7]; [@B28]). The extended tail domains of axonal ankyrins have the potential to interact with cytoskeletal elements, and thus to couple L1 CAM molecules to cytoplasmic proteins in addition to the membrane-associated spectrin--actin network.

L1 CAMs and ankyrins are candidates to collaborate in a major structural pathway, involving both extracellular and intracellular interactions, which is used in diverse contexts in the developing and adult nervous system. This report presents evidence for functional coupling between L1 and 440-kD ankyrin~B~ in premyelinated axon tracts in the neonatal mouse nervous system. Disruption of the ankyrin~B~ gene in the mouse results in a phenotype similar to, but more severe, than the L1 knock-out in mice and L1 mutations in humans, as well as loss of L1 from premyelinated axon tracts. These findings provide evidence that ankyrins and L1CAMs associate in vivo, and furthermore identify the genes and alternatively spliced variants involved in L1 CAM--ankyrin interactions in premyelinated axons.

Materials and Methods {#MaterialsMethods}
=====================

Gene Targeting
--------------

A clone containing 17 kb of the *ank2* gene was isolated from a 129SVJ genomic lambda fix II library using a probe that covers nucleotides 2443-- 2805 of the human ankyrin~B~ cDNA. A novel NotI site was introduced within an exon in the spectrin-binding domain, and this site was used to introduce a cassette that included the neomycin resistance gene (pMC1neo polyA vector; Stratagene, La Jolla, CA), an in-frame HA epitope, and a stop codon. An XhoI/HindIII fragment containing the thymidine kinase gene (from the vector pIC19R) was added to the construct. ES cells were transfected by electroporation with the linearized targeting construct, neomycin- and gancycolivir-resistant clones were isolated, and homologous recombination was verified by Southern blotting (see Fig. [1](#F1){ref-type="fig"} *B*). ES cells were injected into blastocysts from C57Bl/6 mice and implanted in C57Bl/6 pseudopregnant mothers. Male chimeric progeny were mated with C57Bl/6 females to generate heterozygous mice. Homozygous mice were produced from none-littermate heterozygous mice. ES cell culture, transfection, and blastocyst injection were performed in the laboratory of Dr. Beverly Koller (University of North Carolina, Chapel Hill, NC) ([@B33]; [@B27]).

Magnetic Resonance Imaging
--------------------------

Magnetic resonance (MR) microscopy was performed on a General Electric (Fremont, CA) 7.1 Tesla unit, 15-cm bore size, equipped with shielded gradient coils. A Helmholtz coil especially designed for MR microscopy of fixed specimens at 300 MHz was used for imaging ([@B1]). Formalin-fixed brains were suspended in Fomblin (perfluoropolyether; Ausimont, Inc., Morristown, NJ) to minimize dehydration and to limit susceptibility effects at the surface. Data was acquired as anisotropic arrays with an aspect ratio of 1:1:2 with the following acquisition parameters: (*a*) 18.2-h scan time; (*b*) 20-ms echo time; (*c*) 1,000-ms repetition time, diffusion gradient pulse (sine bell-shaped) durations of 5 ms; (*d*) diffusion gradient separation of 12.2 ms; (*e*) large diffusion gradients of 35 Gauss/cm, resulting in a diffusion-weighting factor of 965 s/mm^2^, 256 × 256 × 128 digital resolution; and (*f*) voxel size of 39 × 39 × 78 μm. All images were analyzed using NIH Image 1.68 (public domain from The National Institutes of Health) and VoxelView Ultra (Vital Images, Inc., Fairfield, IA) for three-dimensional rendering.

Analysis of Tissues
-------------------

Immunofluorescence was performed with 5--10-μm frozen brain sections, which were prepared and stained as described ([@B32]). Affinity-purified rabbit antibodies were raised against the human COOH-terminal domain (residues 1551--1813) and 440-kD--specific tail domain ([@B7]) of ankyrin~B~ using recombinant proteins expressed in bacteria as antigens as described ([@B32]). Chick antibody against the 270/480-kD ankyrin~G~ has been described elsewhere ([@B32]). Rabbit polyclonal antibody against neurofascin was described in [@B11]. Antibody against L1 was purchased from Boehringer Mannheim Corp. (Indianapolis, IN). Electron microscopy was performed with optic nerve fixed with 4% glutaraldehyde and subsequently embedded in Epon. To determine the sizes of axons in the knock-out and the control mouse optic nerves, a sheet of paper containing a hole with dimensions of 8 × 8 cm was mounted on the electron micrographs, and the number of axons that appeared in the hole were counted. Northern and Southern blots ([@B42]) and immunoblots ([@B32]) were performed as described. Antibodies used in immunoblotting experiments are anti-L1, a protein A affinity-purified polyclonal antibody (a generous gift from Dr. Patricia Manness of the University of North Carolina at Chapel Hill); polyclonal antispectrin and polyclonal antineurofascin as described in previous reports ([@B23]; [@B11]); and polyclonal anti-NCAM, purchased from Chemicon (Temecula, CA).

Results {#Results}
=======

Ankyrin~B~ (−/−) Mice Exhibit Brain Malformations Resembling Defects Caused by L1 Mutations in Humans and Mice
--------------------------------------------------------------------------------------------------------------

The *ank2* gene encoding ankyrin~B~ was disrupted by homologous recombination (Fig. [1](#F1){ref-type="fig"} *A*), and ankyrin~B~ +/+, +/−, and −/− mice (*n* = 325) were identified by Southern blots (Fig. [1](#F1){ref-type="fig"} *B*) (Materials and Methods). This study is based on the first-generation progeny with a genetic background of 1:1 129SVJ to C57Bl/6. Brains of ankyrin~B~ (−/−) mice exhibited nearly complete loss of a major 13-kb mRNA transcript encoding the 440-kD ankyrin~B~ ([@B31]) as well as loss of less abundant 8- and 5-kb transcripts encoding 220- and 150-kD ankyrin~B~ polypeptides, respectively (Fig. [1](#F1){ref-type="fig"} *C*). 440- and 220-kD ankyrin~B~ polypeptides were undetectable in homogenates of brains of ankyrin~B~ (−/−) mice by immunoblotting (Fig. [1](#F1){ref-type="fig"} *D*). A minor 150-kD polypeptide in the ankyrin~B~ (−/−) mice still is barely detectable in original gels, although not in the published version. 150-kD ankyrin~B~ lacks a membrane-binding domain ([@B39]). Apparently expression of the 150-kD ankyrin~B~transcript is less affected by disruption of an exon in the spectrin binding domain (Materials and Methods).

440-kD ankyrin~B~ is a major isoform in the early postnatal period, as noted previously ([@B31]). Ankyrin~B~ is also expressed in heart where the major isoform of 220 kD was undetectable in ankyrin~B~ (−/−) mice (Fig. [1](#F1){ref-type="fig"} *D*).

Ankyrin~B~ (−/−) mice were born in nearly Mendelian ratios of 1:3 (81/325), demonstrating normal survival during fetal development. However, over half of the ankyrin~B~ (−/−) animals were dead or dying (and therefore killed) on the first postnatal day, and 95% by 8 d (*n* = 81) (Fig. [2](#F2){ref-type="fig"} *B*). A few mutant mice survived until postnatal day 20 (4 out of 81). Mice that did survive to 2 wk were about 25% of the weight of littermates (*n* = 8) and exhibited abnormal locomotion and balance (Fig. [2](#F2){ref-type="fig"} *A*).

Three-dimensional diffusion-weighted magnetic resonance microscopy (DWM) of formalin-fixed brains from a litter of 1-d-old mice (three mutant and three normal) was performed to obtain general information on gross morphology and accurate measurements of ventricle volumes. We used DWM, which measures diffusion of free proton spins to get optimal anatomical resolution. Brain anatomy is revealed in detail with DWM because proton diffusion within regions composed of oriented axon fiber tracts and those comprised of cell bodies is markedly different ([@B3]).

Total brain and cerebellar volumes in the ankyrin~B~ (−/−) brains were nearly identical to those of (+/+) and (+/−) littermates (Table [I](#TI){ref-type="table"}). However, volumetric measurements of the ventricular systems revealed a significant sevenfold enlargement of the lateral ventricles in the ankyrin~B~ (−/−) brains compared with controls (Table [I](#TI){ref-type="table"}; Fig. [3](#F3){ref-type="fig"}). In addition, an enlarged lateral ventricle is easily visualized in Fig. [3](#F3){ref-type="fig"}. Enlargement of lateral ventricles of ankyrin~B~ (−/−) mice was not associated with occlusion of the cerebral aqueduct, which is closed in Fig. [3](#F3){ref-type="fig"} but was patent in other sections (not shown). The extent of lateral ventricle dilation in neonatal ankyrin~B~ (−/−) mice is in agreement with that reported for some strains of adult L1 (−/−) mice ([@B9]; [@B17]). [@B17] found a twofold enlargement of both the frontolateral and fourth ventricle in adult L1 (−/−) mice. Ankyrin~B~ (−/−) mice did not exhibit fourth ventricle enlargement; however, they did not survive beyond day 21, and the full extent of enlargement of brain ventricles could therefore not be determined. L1 (−/−) mice in some genetic backgrounds do not exhibit enlarged ventricles ([@B9]). Hydrocephalus is also variable in extent in humans with L1 mutations, even within the same kindred ([@B15]). L1 hydrocephalus also is associated with a patent aqueduct of Sylvius in some cases ([@B14]; [@B47]).

L1 mutations in mice and humans are associated with abnormalities in the pyramidal tracts and corpus callosum ([@B15]; [@B8]). DWM images revealed the presence of the corpus callosum and internal capsule in sagittal sections as well as pyramidal tracts in coronal sections in control mice (Fig. [3](#F3){ref-type="fig"}). The corpus callosum, internal capsule, and pyramidal tracts could not be resolved in brains of ankyrin~B~ (−/−) mice (Fig. [3](#F3){ref-type="fig"}). Histological brain sections also reveal a reduction in the corpus callosum in ankyrin~B~ (−/−) mice, with nearly complete absence of the anterior portion revealed in a sagittal section (Fig. [5](#F5){ref-type="fig"}). The corpus callosum also was greatly reduced in coronal sections of ankyrin~B~ mutant brain (Fig. [5](#F5){ref-type="fig"}). Hypoplasia of the corpus callosum was observed in 16/26 (postnatal days 1--5) mutant mouse brains examined by coronal sections. Some of the variability in detection of reduction of the corpus callosum may be due to selective loss of anterior relative to posterior regions.

Loss of L1 in Premyelinated Axon Tracts in the Central Nervous System of Ankyrin~B~ (−/−) Mice
----------------------------------------------------------------------------------------------

The similarities in phenotype of ankyrin~B~ (−/−) mice and L1 (−/−) mice suggested the possibility that ankyrin~B~and L1 are coexpressed in the nervous system. Evidence in support of segregation of L1 with ankyrin~B~ and of neurofascin with ankyrin~G~ is presented in Fig. [4](#F4){ref-type="fig"}. Neurofascin has previously been identified at axon initial segments and nodes of Ranvier, which are sites that also contain high local concentrations of 270/480-kD isoforms of ankyrin~G~ ([@B11]; [@B32]). Neurofascin and 270/480 ankyrin~G~ are colocalized at axon initial segments in the neonatal cerebral cortex (Fig. [4](#F4){ref-type="fig"}). However, in neonatal mouse brain, neurofascin and 270/480 ankyrin~G~ were absent from premyelinated axon tracts, including the corpus callosum (Fig. [4](#F4){ref-type="fig"}, *lower panels*) as well the optic nerve and other sites in the central nervous system (data not shown). L1 and 440 ankyrin~B~, in contrast, codistributed in premyelinated axon fiber tracts in the cerebral cortex (Fig. [4](#F4){ref-type="fig"}) and throughout the CNS (Figs. [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}).

440-kD ankyrin~B~ and L1 are colocalized in premyelinated axons located in long fiber tracts in brain (corpus callosum, internal capsule, fornix, striatum, and olfactory tract) (Fig. [5](#F5){ref-type="fig"}) as well as spinal cord (pyramidal tract and lateral columns) (Fig. [6](#F6){ref-type="fig"}). Similar patterns of ankyrin~B~ staining in axon tracts were observed with antibodies against the COOH terminus, which react with all known alternatively spliced forms as with antibodies against 440-kD ankyrin~B~ (not shown). These patterns of distribution of L1 are consistent with previous studies ([@B2]; [@B25]; [@B34]). Brain and spinal cord sections of ankyrin~B~ (−/−) mice exhibited no staining with antibody against the COOH terminus of ankyrin~B~, confirming both the efficacy of gene disruption and specificity of the antibody.

L1 staining is reduced in premyelinated axon tracts in brains and spinal cords of ankyrin~B~ (−/−) mice (Figs. [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). The corpus callosum and internal capsule are reduced or absent in mutant animals (Fig. [5](#F5){ref-type="fig"}) (16/26), as noted above. However, fiber tracts in the brain that still were present and exhibited major reduction in L1 staining include the fimbria and stria terminalis (Fig. [5](#F5){ref-type="fig"} *A*). L1 staining in the pyramidal tract and lateral columns of the spinal cord also is greatly reduced (Fig. [6](#F6){ref-type="fig"}). Ankyrin~B~ (−/−) animals exhibited variability with respect to L1 staining, with about 50% having less pronounced differences. For example, L1 staining still is evident in the sagittal section shown in Fig. [5](#F5){ref-type="fig"} *B*. However, littermate control animals always exhibited strong L1 staining.

Loss of L1 in ankyrin~B~ (−/−) mice is also demonstrated by immunoblotting of brain tissue (Fig. [7](#F7){ref-type="fig"}). It was not feasible to obtain tissue samples from particular anatomical sites such as corpus callosum or optic nerve (see below), where loss of L1 is most prominent. Therefore, intact brains of a control and a mutant postnatal day 7 mouse were evaluated for levels of L1, neurofascin, NCAM, and spectrin (*n* = 1) (Fig. [7](#F7){ref-type="fig"}). Expression levels of neurofascin and NCAM exhibited no detectable change in the brain of the ankyrin~B~ (−/−) mouse. Moreover, levels of β~G~-spectrin also were unchanged (Fig. [7](#F7){ref-type="fig"}). However, immunoblots of the same gel samples with antibody against L1 revealed a 30--40% percent reduction in amounts of 200-, 135-, and 43-kD cross-reacting polypeptides (Fig. [7](#F7){ref-type="fig"}). These results demonstrating partial loss of L1 are consistent with reduction of L1 in localized sites detected by immunofluorescence.

Loss of L1 staining in ankyrin~B~ (−/−) brain and spinal cord raises questions of whether lack of ankyrin~B~ impairs delivery of L1 to axons, whether L1-expressing axon tracts never form and are simply absent, and/or whether L1-expressing axons are present initially but subsequently degenerate. The optic nerve provides a simplified, easily identifiable anatomical site for addressing issues related to L1 behavior and axonal degeneration in ankyrin~B~ (−/−) mice. The premyelinated optic nerve has previously been identified as a site where the 440-kD ankyrin~B~ is the sole ankyrin ([@B7]), and also expresses high levels of L1 ([@B2]). 440-kD ankyrin~B~ and L1 both exhibit a dramatic down-regulation coincident with myelination and are not expressed in adult myelinated axons of the optic nerve ([@B2]; [@B7]).

Transverse sections through optic nerve at postnatal days 1--3 revealed unreduced staining for L1 in ankyrin~B~ (−/−) mice, even though ankyrin~B~ staining was absent (*n* = 7) (Fig. [8](#F8){ref-type="fig"}). These observations establish that at least early in the postnatal period, optic nerve axons are present, and that L1 is delivered to axons in the absence of ankyrin~B~. However, L1 staining disappeared from optic nerves of ankyrin~B~ (−/−) mice by around postnatal day 7, although the nerve itself was still present (Fig. [8](#F8){ref-type="fig"}) (*n* = 6). Optic nerves of normal mice retained L1 and ankyrin~B~ (Fig. [8](#F8){ref-type="fig"}). In contrast to L1, levels of NCAM were unchanged in the optic nerve section of ankyrin~B~ (−/−) mice at postnatal day 7 (Fig. [8](#F8){ref-type="fig"}). Neurofascin was only found at the initial segments of the premyelinated optic nerve axons and was absent from the optic nerves of both control and ankyrin~B~ (−/−) mice. Electron micrographs (see below; Fig. [9](#F9){ref-type="fig"}) reveal that myelination occurred with only a few axons at this stage and was limited to a few loops of myelin. The normal loss of L1 accompanying myelination therefore had not yet begun at the time when L1 disappeared from ankyrin~B~ (−/−) optic nerves.

Degeneration of the Optic Nerve in Ankyrin~B~ (−/−) Mice
--------------------------------------------------------

Electron microscopy of transverse sections of the postnatal day 1 optic nerve revealed relatively normal axon profiles in ankyrin~B~ (−/−) mice, although the average axon cross-sectional area was increased about 20% (see Materials and Methods; data not shown). Axons were packed in tightly assembled arrays, indicating that some level of axon fasciculation occurs in the absence of ankyrin~B~. Sections of postnatal day 9 optic nerve reveal a major change in axons of ankyrin~B~ (−/−) mice (Fig. [9](#F9){ref-type="fig"}). Many axons were increased in diameter up to eightfold compared with the normal axon and contained multivescicular bodies. Longitudinal sections demonstrated increased diameter along the length of ankyrin~B~ (−/−) axons (not shown). Axon fasciculation also was impaired in sections of ankyrin~B~ (−/−) optic nerve with many examples of loss of direct axon--axon contacts (Fig. [9](#F9){ref-type="fig"}).

All ankyrin~B~ (−/−) mice surviving until postnatal day 21 exhibited nearly complete degeneration of the optic nerve (*n* = 8) (Fig. [10](#F10){ref-type="fig"}). The optic nerve of ankyrin~B~ (−/−) mice thus forms initially with normal axonal delivery of L1 and subsequently degenerates. Ankyrin~B~ and ankyrin~G~ are coexpressed before myelination in most other nerves, including the trigeminal nerve ([@B32]). The optic nerve, which only has ankyrin~B~, apparently is especially vulnerable in ankyrin~B~ (−/−) mice.

Discussion {#Discussion}
==========

This study describes dramatic consequences of deficiency of ankyrin~B~ in mice that allow survival until birth but result in hypoplasia of the corpus callosum and pyramidal tracts, dilated lateral ventricles, followed by extensive degeneration of the optic nerve, and death by postnatal day 21. This phenotype is similar to, but more severe, than those observed in L1 (−/−) mice and human patients with L1 mutations. L1 was reduced or absent in ankyrin~B~ (−/−) mutant mice in premyelinated axons of long fiber tracts in the brain and spinal cord as well as optic nerve at postnatal day 7. These findings provide the first evidence for a role of ankyrin~B~ in the vertebrate nervous system and support a functional connection between ankyrin~B~ and L1 that is required for maintenance of premyelinated axons in vivo.

L1 deficiency in mice is compatible with survival to adulthood ([@B9]; [@B8]; [@B17]) and represents a much less severe phenotype than ankyrin~B~ deficiency. Other L1 CAM family members (CHL1, NrCAM, NgCAM, and neurofascin) may functionally compensate for L1 in L1 (−/−) mice. In addition, ankyrin~B~ is likely to have additional roles unrelated to L1, particularly early in development when some L1 CAMs are tyrosine phosphorylated and therefore incapable of binding to ankyrin ([@B18]; [@B49]; [@B20]). Conversely, L1 and other members of the family are likely to have ankyrin-independent functions when these proteins are tyrosine phosphorylated. This study demonstrates that early in development, L1 is capable of axonal transport to the optic nerves of ankyrin~B~ (−/−) mice, implying that its delivery to the plasma membrane and axonal targeting are independent of ankyrin~B~. It will be of interest to determine the phosphorylation state of L1 in the early postnatal optic nerve, where this protein is transported to axons in the absence of ankyrin~B~ (Fig. [6](#F6){ref-type="fig"}).

The mechanism for loss of L1 in ankyrin~B~ (−/−) axons is not known, but it could result from reduced stability of L1 in the absence of ankyrin~B~. A similar situation in which loss of a cytoskeletal protein results in reduction of integral proteins has been found in *mdx* mice, where absence of dystrophin results in reduction of dystrophin-associated proteins ([@B35]). A practical consequence of reduced expression of interacting proteins is that a characterization of patterns of gene or protein expression in the ankyrin~B~ (−/−) mouse brain may yield heretofore unidentified proteins whose functions involve ankyrin~B~.

The striking increase in axonal diameter of optic nerve axons suggests the hypothesis that the absence of ankyrin~B~ leads to loss of mechanical stability of axons. Ankyrin~B~ could contribute to axonal membrane support by connecting the spectrin--actin network to the plasma membrane, as occurs in erythrocytes ([@B40]). In this case, axonal swelling would be analogous to hereditary spherocytosis of erythrocytes observed in cases of ankyrin~R~ mutations ([@B13]). The tail domain of the 440-kD ankyrin~B~ potentially could extend several hundred nanometers into the axoplasm and also mediate interactions with structural proteins in addition to the spectrin skeleton. L1-mediated connections between axons combined with coupling to the spectrin--actin network via ankyrin could provide an additional level of mechanical support for axon bundles. Such a transcellular network based on L1 and ankyrin is analogous, in a formal sense, to the epidermis, where keratinocytes are connected through desmosomes on their outer surfaces, and desmosomes are interconnected via intermediate filaments. The consequence in both cases is a mechanical buffering system capable of distributing shear stresses throughout the tissue. It is of interest in this regard that the brains of ankyrin~B~ (−/−) are much more fragile and susceptible to damage during dissection compared with brains of normal mice (data not shown).

Ankyrin~B~ and L1 are coexpressed and may interact at sites in addition to premyelinated axons. Unmyelinated axons in the molecular layer of the adult cerebellum express 440-kD ankyrin~B~ as well as L1 ([@B31]; [@B34]; [@B30]). 220-kD ankyrin~B~ is expressed in glial cells, including Schwann cells and astrocytes (Kordeli et al., 1990; [@B31]; [@B30]), and could associate with alternatively spliced forms of L1 present in these cells ([@B34]). L1 is expressed outside of the nervous system in cells including lymphocytes ([@B29]). It will be of interest in future experiments to examine L1 distribution and function in ankyrin~B~ (−/−) mice at sites of axo--glial contact and in the immune system.

Ankyrin and L1 have both been implicated in axon guidance. L1-deficient mice exhibit defects in guidance of corticospinal axons across the pyramidal decussation ([@B8]). Ankyrin (*Unc-44*) mutations in *Caenorhabditis elegans* result in abnormal axon outgrowth and guidance ([@B38]). It is not clear from the current data if ankyrin~B~ and L1 collaborate in axonal guidance, or if ankyrin~B~has any role in axonal guidance. It will be of interest to trace the paths of axons in the optic nerve and corticospinal tracts of ankyrin~B~ (−/−) mice to determine possible defects in decussation and in final arrival at neuronal targets. Consequences of ankyrin~B~ deficiency, including degeneration of the optic nerve, could be secondary to defective targeting of axons to their normal sites accompanied by apoptosis caused by lack of retrograde transport of appropriate factors.

The accumulated L1 mutations characterized in human families provide a valuable database for structure--function studies of the L1 molecule ([@B16]). One missense mutation in the L1 cytoplasmic domain results in conversion of Y1229 to H and clinical disease ([@B45]). The Y1229H mutation of the FIGQY tyrosine is of particular interest with respect to ankyrin. Recent analysis of structural requirements for L1 CAM binding to ankyrin has demonstrated that the FIGQY tyrosine is essential for ankyrin binding ([@B22]; [@B48]). Moreover, mutation of the FIGQY tyrosine to histidine abolishes ankyrin binding activity of neurofascin ([@B48]). These considerations suggest the possibility that ankyrin binding activity of L1 is also abolished by the Y1229H mutation, and that loss of ankyrin binding results in loss of L1 function in humans.
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![Generation of ankyrin~B~ (−/−) mice by homologous recombination. (*A*) The strategy for placing the neomycin resistance cassette into an exon of the *ank2* gene. The probe for the Southern blot is indicated. Sites for restriction enzymes, HindIII (*H*) and BamHI (*B*) are indicated. (*B*) Southern blot demonstrating homologous recombination using a probe as indicated in *A*. The insertion of an extra BamHI site in the targeted locus produces a band at 4.0 kb. (*C*) Northern blot with a probe derived from cDNA encoding the spectrin-binding domain of ankyrin~B~, demonstrating loss of ankyrin~B~ transcripts in (−/−) animals. The amount of total RNA loaded on each lane was indicated by the 18S ribosomal RNA, which was stained with methylene blue. (*D*) Immunoblotting of brain and heart homogenate using an antibody to the COOH terminus of ankyrin~B~ that recognizes all known alternatively spliced variants.](JCB9808052.f1){#F1}
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Photograph of an ankyrin~B~ (−/−) mouse and a normal littermate (*A*) and postnatal survival of ankyrin~B~ (−/−) mice (*B*). Animals shown in *A* were 11 d old. The mutant mouse was 25% of the weight of the normal animal.
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Volume of Brain Regions by MRM

  Parameter                     Ankyrin~B~ (−/−) (*n* = 3)      Wild-type (*n* = 3)      *P* value
  -------------------------- -- ---------------------------- -- --------------------- -- -----------
                                *mm* ^3^                        *mm* ^3^                 
  Total brain volume            82 ± 10                         98 ± 10                  0.14
  Cerebellar volume             4.6 ± 0.4                       4.9 ± 0.4                0.32
  Fourth ventricle volume       0.13 ± 0.03                     0.11 ± 0.03              0.36
  Lateral ventricle volume      0.20 ± 0.07                     0.03 ± 0.01                0.017

![MR microscopy images of brains of normal littermate and ankyrin~B~ (−/−) mice. Parasagittal of brains from a normal littermate (EF5 +/+) and an ankyrin~B~ (−/−) mouse are in red boxes on the right. Sections indicated by blue and green lines are displayed on the left. Although unmyelinated, the internal capsule and pyramidal tracts are clearly visible in the normal brain (*top left*, *blue* and *green panels*) and were not evident in the mutant (*bottom left*, *blue* and *green panels*). The internal capsule and corpus callosum are also visualized in the parasagittal sections of the normal brain (*top right*, *red panel*) and could not be resolved in the mutant (*bottom right*, *red panel*). The lateral ventricles were abnormally enlarged in mutant brains (*bottom left*, *blue panel*). One ankyrin~B~ (−/−) brain exhibited severe malformation of most brain structures and is not shown. These images represent a milder phenotype.](JCB9808052.f3){#F3}

![L1 staining is reduced in long fiber tracts in brains of ankyrin~B~ (−/−) mice. Coronal sections of brains close to the optic chiasm (*A*) and parasagittal sections (*B*) of normal littermate (*top rows*) and ankyrin~B~ (−/−) (*bottom rows*) mice stained by immunofluorescence using an antibody against the ankyrin~B~ COOH terminus cross-reacting with all known ankyrin~B~ polypeptides (*left column*) and an antibody against L1 (*middle column*). The composite staining for both ankyrin~B~ (*red*) and L1 CAM (*green*) is in the right column. The corresponding anterior and posterior portions of corpus callosum in wild-type littermate and the knock-out mice are indicated by the arrow and arrowhead, respectively. Similar results were obtained with antibody against the tail domain specific for the 440-kD ankyrin~B~ (not shown). *CC*, corpus callosum; *Fo*, fornix; *Fi*, fimbria; *IC*, internal capsule; *CPu*, caudate putamen; *ST*, stria medullaris. Bars: (*A*) 100 μm; (*B*) 50 μm.](JCB9808052.f5){#F5}

![Codistribution of L1 with ankyrin~B~ in premyelinated axon tracts and codistribution of neurofascin with ankyrin~G~ in axon initial segments in neonatal mouse brain. The sections through cerebral cortex of neonatal mouse brain were double labeled with antibodies to L1 (*A*) and ankyrin~B~ (*B*, composite image shown in *C*) or antibodies to neurofascin (*D* and *D′*) and ankyrin~G~ (*E* and *E′*, composite images shown in *F* and *F′*). The results show L1 and ankyrin~B~ codistributed in the axon tracts while neurofascin and ankyrin~G~ colocalized at initial segments of axons. The images shown in *D′--F′* were taken from the corpus callosum portion of the same section shown in *D--F*. Bars, 10 μm.](JCB9808052.f4){#F4}

![L1 staining is reduced in the pyramidal tracts and lateral columns in the spinal cords of ankyrin~B~ (−/−) mice. Transverse sections of spinal cords at thoracic vertebrae 8 of normal littermate (*top row*) and ankyrin~B~ (−/−) (*bottom row*) mice were double stained with an antibody against the ankyrin~B~ COOH terminus cross-reacting with all known ankyrin~B~ polypeptides (*left column*) and an antibody against L1 (*middle column*). The composite staining for both ankyrin~B~ (*red*) and L1 CAM (*green*) is in the right column. *PT*, pyramidal tract; *LC*, lateral column. Bars, 100 μm.](JCB9808052.f6){#F6}

![Immunoblots of neurofascin, NCAM, β~G~ spectrin, and L1 in brain tissue from ankyrin~B~ (+/+) and (−/−) mice. Polypeptides in total brain homogenates of an ankyrin~B~ mouse (−/−) (*left lanes*) and a (+/+) littermate (*right lanes*) mouse were separated on a 3.5--17.5% SDS--polyacrylamide gel and either stained with Coomassie blue or transferred to a nitrocellulose membrane. Duplicate membranes were blotted with polyclonal antibodies to ankyrin~B~ (*ankB*), spectrin (*spec*), neurofascin (*Nf*), NCAM, and L1, and bound antibodies were detected with ^125^I-labeled protein A. L1 polypeptides of 200, 135, and 43 kD are marked on the left. The extent of labeling was quantitated by a phosphoimager. Immunoblots were scanned to a phosphoimager and analyzed using ImageQuant software developed by Molecular Dynamics (Sunnyvale, CA). Compared with the wild-type littermate, L1 polypeptides of 200, 135, and 43 kD were reduced by 38, 29, and 27%, respectively, in ankyrin~B~ (−/−) brain samples. The relative amounts of spectrin, neurofascin, and NCAM in the ankyrin~B~(−/−) samples were 0.95, 1.01, and 1.06 that of wild-type samples, respectively.](JCB9808052.f7){#F7}

![L1 is initially expressed and subsequently lost in premyelinated optic nerves of ankyrin~B~ (−/−) mice. Transverse sections through the optic nerves of postnatal day 1 mice (*P1*) and day 7 mice (*P7*) were double stained with antibodies against ankyrin~B~ COOH terminus (*top row*) and L1 (*middle row*). The P7 optic nerve sections also were double stained with antibodies to NCAM (*right top panels*) and L1 (*right middle panels*). The composite images for both ankyrin~B~ (*red*) and L1 CAM (*green*) or NCAM (*red*) and L1 (*green*) were shown in the bottom row. The genotype of the mice was marked with −/− for the knock-out mouse and WT for the wild-type mouse. Bars, 10 μm.](JCB9808052.f8){#F8}

![Electron micrographs of transverse sections of optic nerves of day 1 (*top row*) and day 9 (*bottom row*) normal mice (*right)* and ankyrin~B~ (−/−) mice (*left*). Sections of optic nerves were obtained within 1 mm of the optic chiasm and matched as closely as possible between mutant and control animals. Several dilated axons are outlined between the two arrowheads. Arrows denote sites where axons are not in contact with each other. A mulivescicular body in a day 9 mutant axon is marked by an asterisk. Bar, 1 μm.](JCB9808052.f9){#F9}

![Degeneration of optic nerves of ankyrin~B~ (−/−) mice. Photograph of optic nerves (*OpN*) and trigeminal nerves (*TrN*) of postnatal day 20 normal littermate (*top*) and ankyrin~B~ (−/−) (*bottom*) mice. Note the nearly complete loss of the optic nerve in the mutant mouse.](JCB9808052.f10){#F10}
